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Abstract 
This study was built on the premise that better diagnosis of cancers has been associated with 
early detection. Genetic studies have been identified as a good intervention tool to improve 
diagnosis and little is known about gene-protein-gene interaction. Therefore this study was 
designed with the aim of detecting gene-protein-gene interactions. The objective of this study 
was thus to have a better understanding of the interactions among genes and breast cancer 
biomarkers using a more robust statistical model. 
      The study was carried on the premise that breast cancer is the top cancer in women in the 
developing world and particularly in Africa where it occurs with the highest incidence. Most 
risk-reduction strategies cannot eliminate the majority of breast cancers that develop in 
countries of the developing world where breast cancer is diagnosed in very late stages. As a 
result early detection in order to improve breast cancer outcome and survival remains the 
cornerstone of breast cancer control. This justified the timing of this study. 
       A log-linear built model was fitted into breast cancer data available at the Advanced 
Medical Research and training Institute of the University College hospital-University of 
Ibadan-Nigeria. Secondary breast cancer data was collected from some breast cancer patients 
at the Institute of Advanced Medical Research and Training Institute (I.M.R.A.T), of 
University College Hospital (U.C.H) Ibadan-Nigeria. Different levels of Estrogen receptor 
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alpha (E.R), Prostrogen Receptor (P.R) and HER-2-Neu were analyzed in this study. Data was 
reduced to contingency tables whose effect was distortion of their continuous nature into 
discrete form. Although this led to a loss of data identity, it was considered necessary to make 
computations feasible. 
The t-test statistic (analog of the likelihood ratio statistic) and Wald test were used to test the 
extent of fit (level of statistical significance) of the regression coefficients (the betas).  The 
findings revealed that there is a statistical significance in the interaction between Prostrogen 
Receptor (P.R) and HER-2-NEU only when Estrogen receptor alpha (E.R) level was low. This 
implies that patients with breast cancer will benefit more from treatment at this level which 
also corresponds to the early stages of breast cancer. 
Keywords: Log linear Model, Breast cancer 
 
1.0 Introduction 
      Cancer as a disease is yet to get effective treatment as such. Most treatments have been 
palliative. According to (American Cancer Society, 2014) the best prognoses have been associated 
with early detection of tumours. According to (Genetics Home Reference, 2014) breast cancer has 
been associated with a build-up of mutations in critical genes which control tissue growth in the breast. 
According to Putta(1997), a division or repair of damaged DNA allows certain breast cancer cells to 
grow abnormally, multiplying without control, leading to formation of tumour.  According to him, 
many researchers have looked at genetic engineering in their search for a breakthrough in the treatment 
of cancers. The ongoing search for the causes of breast cancer currently involves an identification of 
genetic variations in a region of DNA that maybe associated with breast cancer. According to 
(American Cancer Society, 2014) the foundation of modern strategies of early breast cancer tumour 
detection is based on the triad and true method. This, according to him, includes mammography and 
breast magnetic resonance imaging (M.R.I). (Olopade, 2004) suggests that the recognition of the 
genetic defects can be used to differentiate prognosis of tumors. According to him, the genetic testing 
for breast cancer includes the analysis of genes, namely: P53 (Tumour Suppressor Gene), PTEN 
(Phosphates and Tension Homolog-Mutated in Multiple Advanced cancers 1), BRCA-1(Breast Cancer 
gene 1), BRCA-2 (Breast Cancer gene 2), HER-2 NEU (Human Epithelial Receptor Hormone), ATM 
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(Ataxia Telengiectasia Mutated), among other genes and Mutations. The Gill model has just been 
developed to determine the risk of Carcinoma of the breast in a patient. Currently, test for breast 
cancer is performed by nipple aspirations to collect fluid from the breast for cytology. 
       Researchers from the U.S national cancer institute have identified genetic variations in a 
region of DNA that may be associated with breast cancer. Their findings indicate that women with the 
variation have almost 1.4 times greater chance of developing breast cancer compared to those without 
the variation. Genetic, hormonal and Mutational data can neither be classified as independent or 
dependent variables. This was the grounding and justification for our use of a log-linear model to fit to 
the breast cancer data. Little work has been reported in Africa on this issue partly due to limited 
resources. The Institute of Advanced Medical research and Training of the University College 
Hospital-Ibadan serves as a databank for genes on breast cancer collected from different hospitals in 
Nigeria. (George & McClloch, 1993)used the stochastic Search Variable selection Procedure (SSVSP) 
to analyze the interactions among the genes. This procedure was, however, later found to be deficient, 
in the sense that, while this method of variable selection improves the prediction for complex model 
output, it is difficult to interpret the relative contribution of each covariate or groups of covariates, to 
the p-dimensional fitted surface. The procedure also has limited applications when there are few 
exploratory variables, like in our present case. One motivation for the present analysis is to explore the 
interactions and level of statistical significance in the interactions among Estrogen Receptor, 
Prostrogen Receptor and Her-2-Neu biomarkers.  
     Log-linear model analysis uses ANOVA-type notation and assesses the effects of independent 
variables on the dependent variable. In the analysis of contingency tables, we can distinguish two 
situations, that is, one variable is viewed as a response and the remaining variables as explanatory. For 
this case the loglinear model can be adopted to deal with this situation in a way analogous to ANOVA. 
Secondly, as in our case no distinction is made between dependent and explanatory variables. 
Loglinear models are then used to describe the structural relationships among the variables, a kind of 
analysis which is different from ANOVA. This study then, uses this more robust method, the 
log-linear model to describe how the different breast cancer biomarkers possibly interact leading to 
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breast cancer progression. The number of variables in our log-linear model equation is three in number 
which makes it possible to investigate all the possible interactions in our model.       
2.0 Methods 
2.1Contingency Table Formation 
Our interest in his work concerned the analysis of three expression profiles namely,     
HER-2-Neu, Estrogen Receptor and Prostrogen receptor. 
Table 1: Observed frequencies for expression levels of HER-2-Neu controlling for ER 
level 
  HER-2-Neu STATUS  
Estrogen Receptor Prostrogen 
Receptor 
 Positive            
Negative 
     Total 
 
MODEL 1 
 
˂25% expression level 
˂25% expression 
level (Low) 
˃25% expression 
level(high) 
 77(A11)106(A12) 
 
05(A21)       
09(A22)    
 
 
     183 
 
      14 
 TOTAL  82                     
115    
      197 
MODEL 2 ˃25% expression level ˂25% 
 
 
˃25%   
 6                  
5 
 
 1                  
7 
   11 
 
       8 
 TOTAL  7                 
12       
     19 
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Table 1 Description: Table 1 represents the two models for which analysis was sought. Model 
1represents observed frequencies for Her-2-Neu at the two expression levels of PR of ˂25 and ˃25 
while controlling for ER expression level (at an expression profile level of ˂25%).Model 2 similarly 
represents observed frequencies for Her-2-Neu at the two expression levels of PR of ˂25 and ˃25 
while controlling for ER expression level (at a different expression level ˃25%). 
Table 2: Expected frequencies for expression levels of HER-2-Neu mutations controlling 
for ER level 
  HER-2-Neu STATUS  
Estrogen Receptor Prostrogen 
Receptor 
 Positive            
Negative 
     Total 
 
MODEL 1 
 
˂25% expression 
level 
˂25% expression 
level (Low) 
˃25% expression 
level(high) 
 75(A11)108(A12) 
 
06(A21)       
08(A22)    
 
 
     183 
 
      14 
 TOTAL  82                     
115    
      197 
MODEL 2 ˃25% expression 
level 
˂25% 
 
 
˃25%   
 5                  
6 
 
 3                  
5 
      11 
 
       8 
 TOTAL  8                 
11       
      19 
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Table 2 Description: Table 2 is the table of expected frequencies of HER-2-Neu at the two expression 
levels of PR of ˂25 and ˃25 while controlling for ER expression level (at an expression profile level of 
˂25%).Model 2 similarly represents expected frequencies for Her-2-Neu at the two expression levels 
of PR of ˂25 and ˃25 while controlling for ER expression level (at a different expression level ˃25%). 
Table 3: Table of natural logs of expected frequencies 
  HER-2-Neu STATUS 
Estrogen Receptor Prostrogen Receptor  Positive            
Negative 
 
MODEL 1 
 
˂25% expression level 
˂25% expression 
level (Low) 
˃25% expression 
level(high) 
4.3174.682 
 
1.792         
2.079 
 
 
MODEL 2 ˃25% expression level ˂25% 
 
 
˃25%   
1.609         
1.792 
 
 
1.099        1.609                 
 
Table Description: Table 3 represents a summary of the natural logarithms of the values of the 
expected frequencies. 
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Table 4: Table of beta coefficients for expression levels of her-2-neu mutations controlling 
for ER level (ER˂ 25%)  
 Value of Bi Standard                                
Error 
    Z-Value 
B1 3.2175 0.30457589       10.5638 
 
B2 1.2820 0.30457589    4.2091 
 
B3 -0.1630 0.30457589   -0.5352 
 
B4 -0.0195 0.30457589   -0.2561 
Table Description: Table 4 gives the values of the beta coefficients for Model 1((ER levels ˂25%), 
their standard errors and Z-values. 
Table 5: Beta Values for expression levels of HER-2-Neu controlling for ER level 
(ER˃25%)  
 Value of Bi Standard Error Z-Value 
B1  1.52725  0.43480682  3.5124794 
B2  0.17325  0.43480682  0.39913083 
B3 -0.17325  0.43480682 -0.39845281 
B4  0.08175  0.43480682  0.1880453 
 
Table Description: Table 5 gives the values of the beta coefficients for Model 2   
(ER levels ˃25%), their standard errors and Z-values. 
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2.2 Design Matrix Formulation 
The model was expressed in terms of a general linear model: 
Y=XV +€, 
Where X is the design matrix, Y are log frequencies and € is an error vector. The model in matrix 
terms for a two-way table of C cells with P parameters to be estimated is given by Y=xv +€ whose 
solution is: 
V= (X
I
X)
-1
(X
I
Y) 
where Y is a (C) (1) vector of log expected frequencies, v is a Cx1 vector of parameters to be 
estimated; X is a C x P design matrix with elements determined by the parameters required. 
2.3 The Design Matrix term 
For three predictors X1, X2 and X3, we ended up with three two-way interactions 
(X1X2, X2X3 and X1X3) and one three-way interaction (X1X2X3). This results to the log-linear model: 
Oi= (b0+b1X1+b2X2+b3X3+b4X1X2+ b5 X1X2X3+ €) ---------------------(i) 
€- Is the error term 
Where Oirepresents the outcome. 
This study analysis being one of categorical data, we reformulate model (i) above with an outcome in 
terms of loge as: 
Log Oi= (b0+b1X1+b2X2+b3X3+b4X1X2+ b5 X1X2X3+ Ln (€ijk)---------------------(i) 
For each cell, the U terms which contribute to the model were written down. This resulted to: 
Y1            Log F11                 μ + μ1(1) + μ2(1)  +  μ12(11) 
Y2     =      Log F12    =      μ + μ1(1) + μ2(2) +  μ12(12)   
Y3            Log F21            μ + μ1(2) + μ2(1) +  μ12(21) 
Y4            Log F22                   μ + μ1(2) + μ2(2) +  μ12(22)                 
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The entry in the i-th row and the i-th column of the design matrix was then coded (1) was then 
coded 1 if the i-th parameter was involved in the i-th row and 0 if it was not present. 
2.4 Model Reparameterization 
The design matrix above could not be used as it is because the constructs on the terms leads to 
dependencies. It was therefore necessary to orthogonalise it, leading to the reparameterized 
model: 
                1 1 1 1 
          1 1 -1 -1 
          X=   1 -1 1 -1       
                1 -1 -1 1 
            But B = (X
I
X)
-1
(X
I
Y) 
2.5 Calculation of parameters for model 1 (ER levels ˂ 25%) 
                                             Log F11 
B = (X
I
X)
-1
(X
I
Y) = B = (X
I
X)
-1
(X
I
Y)               Log F12 
                                             Log F21 
Log F22 
             4  0  0   0 
 =      ¼    0  4  0  0 
             0  0  4  0      
            0  0  0  4 
              Β1                     A+B+C+D 
       β=    β2             A+B-C- D 
              Β3         = ¼    A-B+C- D 
β4A-B-C+ D 
                2.87 
               5.128   
       =  ¼   -0.652 
               -0.078                       
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   β1= 3.2175; β2= 1.282 ;β3= -0.163 ;β4= -0.0195 
2.6 Calculation of parameters for model 2 (ER levels ˂ 25%) 
B = (X
I
X)
-1
(X
I
Y)  
              Β1                    A+B+C+D 
       β=    β2             A+B-C- D 
              Β3         = ¼    A-B+C- D 
             B4              A-B-C+ D 
 
                    6.109 
              = ¼   0.693 
                    -0.693 
                   0.327 
                    1.52725 
              =     0.17325 
                    -0.17325 
                  0.08175 
2.7 Test Statistic and Significance testing of model parameters 
2.7.1 Statement of the Hypothesis under test 
The null hypothesis under test is: 
H0: Bi=0, that is Xi has no effect and so is not needed in the model in the presence of all other 
variables (for all values of i). 
The Ratio of the standard errors of estimates is estimated using the formula 
)(. bes
b
=N.I.D (0, 1) under the null hypothesis H0; that is, this ratio is approximately normally 
distributed with mean 0 and variance 1. 
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The variance of the contrast is given by    Ʃ a2 
                                  -------- 
                                 F 
whereas the contrast terms are of the form [¼, ¼, -¼, -¼] 
Such that Ʃ ai = 0, 
That is (¼+ ¼- ¼- ¼) =0 
2.8 Standard Errors of the Beta Values 
It was recalled that the variance is exact for the parameters in the saturated model under 
consideration in the study. Variance of the contrast is: 
Ʃa2 
-----   =   (¼)
2    
+   (¼)
2   
+ (¼)
2   
+  (¼)
2       
=0.09276647(Variance of the contrast) 
F          4.317      4.682      1.79         2.079 
 
   F=Frequency values of the Natural logs table values 
Therefore, Standard error (square root of contrast) = 0.30457589 
2.9 Confidence intervals for statistically significant regression coefficients (at 99%) 
2.9.1 Beta value 1 (β1) for model 1 
Confidence intervals were computed for all the regression coefficients needed in the model as 
follows: 
C.I (β1) = B1±Zα S.E (β1)   
             = 1.52725±2.58 (0.30457589) 
             = [0.7414442, 2.3130558] 
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Hence we were 99% confident that X1 was needed in Model 1 in the presence of all other 
variables, for the given interval.  As a confirmation, the fact that the confidence interval does 
not contain 0 confirms that B1 is different from 0 and is hence needed in the model. 
 2.9.2 Beta value 2 (β2) for model 1 
C.I (β2) = B2±Zα S.E (β2)   
             = 1.282±2.58 (0.30457589) 
             = [0.4961942, 2.0678058] 
Hence we were 99% confident that X2 was needed in Model 1 in the presence of all other 
variables, for the given interval.  As a confirmation, the fact that the confidence interval does 
not contain 0 confirms that B2 is different from 0 and is hence needed in the model. 
2.9.3 Beta values 3 and 4 for model 1 (B3& B4) 
C.I (β3) = B3±Zα S.E (β3)   
             = 0.163±2.58 (0.30457589) 
             = [-0.6228058, 0.9488058] 
and 
C.I (β4) = B4±Zα S.E (β2)   
             = -0.078±2.58 (0.30457589) 
             = [-0.7078058, 0.7078058] 
Hence both X3 and X4 were not needed in Model 1 in the presence of all other variables, for 
the given interval respectively. Both confidence intervals contain 0 which confirms that both 
Variables X3 and X4are not different from 0 and are hence not needed in the model in the 
presence of other variables. 
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Alternative approach was to recognize that     Zcalc    =     B         is almost   N 
(0, 1) which could be  S,e(β) 
Compared against the Z-critical value of 2.58 
 2.9.4 Beta values for model 2 
C.I (β1) = B1±Zα S.E (β1)   
             = 1.52725±2.58 (0.30457589) 
             = [0.7414442, 2.3130558] 
C.I (β2) = B2±Zα S.E (β2)   
             =0.17325 ±2.58 (0.30457589) 
             = [-0.6125558, 0.9590558] 
C.I (β3) = B3±Zα S.E (β3)   
             = -0.71325±2.58 (0.30457589) 
             = [-1.4990558, 0.0725558 ] 
C.I (β4) = B4±Zα S.E (β2)   
             = 0.08175±2.58 (0.30457589) 
             = [-0.7040558, 0.8675558] 
Hence only variable X1 was needed in the model while variables X2, X3 and X4 were not 
needed in Model 2 in the presence of all other variables. Both confidence intervals contain 0 
which confirms that both Variables X3 and X4are not different from 0 and are hence not 
needed in the model in the presence of other variables. 
2.0 Discussion 
      The study revealed that statistical significance is only evident at the early stages of the 
expression of prostrogen receptor, Estrogen receptor and Her-2-Neu Mutations. Her-2-neu mutations 
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exhibit themselves more when the expression profiles of Prostrogen receptor are low, that is, at less 
than 25% expression magnitudes. When the expression profiles of PR mutations are low in terms of 
expressions, the percentage of patients testing Negative for Her-2-Neu mutations outweighed those 
testing positive for the same. The interactions of the mutations PR and HER-2-Neu were found to be 
significant at the low levels of ˂ 25% PR expression profile magnitude. Mutations of HER-2-Neu 
reduced in terms of their expression magnitudes at the higher levels of PR Mutations. The results 
suggest that there is a low risk of contracting breast cancer when the expression levels of any of 
proteins and mutations associated with genes ER and PR are produced in high volumes. However, 
there was no statistically significant relationship between ERT and PR and HER-2-Neu status for this 
level, which is also associated with higher chances of contracting breast cancer. There was a 
statistically significant relationship between ER, PR and HER-2-Neu mutations when HER-2.Neu 
mutations express themselves in low levels of up to ˂ 25%.  
      The study presents new findings in breast cancer research; that is, as the expression magnitude 
of Prostrogen Receptor increases, the expression level of Her-2-Neu reduces, though this was not 
statistically significant.  
3.1 Limitations of the study 
        It was felt that the problem of sparse analysis posed problems in inference. At the high levels 
of expression magnitude of HER-2-Neu mutations, cell frequencies were very low. Whereas cells with 
very low frequencies and by extension empty cells do not greatly affect out type-1 error rate, they 
certainly lower the power (1-B). In addition the saturated loglinear model is not usually the most 
parsimonious model. More, not too much work has been done using the Log-linear model. In addition, 
the scope of analysis done in this study could not be easily extended to analyse non-hierarchical 
models.   
3.2 Recommendations for Future Research 
The distribution of patients by sex was lacking in the data set used to analyse this study. Future 
researchers could thus replicate the study in a different setting when data on the sex distribution is 
available. This data did not also avail the age distribution differentials. It is thus not clear whether age 
was a potential confounder for this study. Future researchers in this area may thus carry out log-linear 
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modelling using data in which the age-distribution differentials are known. Areas for further 
research in this study also include consideration of non-hierarchical models. A solution to the 
problem of zero cells and/ or cells with low frequencies is still unknown, especially when data 
analysis relies on secondary data as was the case for this study. Future bio-statistical 
researchers could therefore develop a log-linear correction for continuity in an attempt to help 
correct this problem. Future researchers could also analyse gene-protein-gene interaction 
using loglinear model but controlling for either Prostrogen or HER-2-Neu mutations. 
Conclusions 
Based on the results of this study, the log-linear model is a more robust model and hence a better 
model for gene analysis. 
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